Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

MedMira Inc V.MIR

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  MMIRF

MedMira Inc is a biotechnology company. It is engaged in the business of research and development and manufacturing of rapid diagnostics and technology.
Price: $0.045 Volume: 54,600
Change: $0.00 % Change: 0.00%
Day High/Low: 0.045/0.04 52 Week High/Low: 0.10/0.04
Last Traded: March 27, 2015 09:10 Transaction Volume: 600
Open: 0.045 Previous Close: 0.045
Bid: 0.045 Ask: 0.05
Bid Size: 50000 Ask Size: 122000
Market Cap: 24.1m Shares Out: 536.4m
PE Ratio: N/A Dividend Yield: N/A

Latest Bullboard Posts

  • RE:MIR sucks--- I better buy some.

    3 stars

    grapevine Please tell me one thing that MEDMIRA has accomplished ? Is it that they completed the 1 million shipment to the Indian...

    2 stars


  • MIR sucks--- I better buy some.

    3 stars

    So Park you woudnt use a MIR hiv test. You seem to be negative on the company and its products. Why is it this board draws so many like...

    1.5 stars


  • RE:RE:RE:WOW!

    3 stars

    I agree, I don't care about Orasure. But look at the chart, it goes up, it goes down. The only thing is they have revenue. MIR NR from...

    1.5 stars


  • RE:RE:WOW!

    0 stars

    If the market doesn't lie, and your company's down 260 million in market capitalization, 4.65 per share in less than two months. Somebody...

    1.5 stars


  • RE:WOW !

    3 stars

    What do you mean?. Quote from Orasure- The Company exceeded $100 million in annual revenues for the first time in its history. Still...

    1.5 stars